Moreover, prostate cancer exosomes can activate TGF-β1-dependent fibroblast differentiation to the myofibroblast phenotype and promote tumor growth and angiogenesis, but the direct use of soluble TGF-β1 cannot achieve these cancer-promoting effects. The gene discussed is TGFB1; the disease is prostate carcinoma.